Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146423 | 0.88 | ACHE (0.54) | ACHEHPGDBCHE | |
| Water SCHEMBL436371 | 0.86 | ACHE (0.53) | ACHEHPGDBCHE | |
| Ammonia Solution, Strong SCHEMBL30096047 | 0.86 | ACHE (0.53) | ACHEHPGDBCHE | |
| Ammonia Solution, Strong SCHEMBL28899074 | 0.86 | ACHE (0.53) | ACHEHPGDBCHE | |
| SCHEMBL17187153 | 0.84 | ACHE (0.53) | ACHEBCHE | |
| SCHEMBL7044948 | 0.81 | ACHE (0.50) | ACHEHPGDBCHEMEN1KMT2A | |
| SCHEMBL30914704 | 0.80 | ACHE (0.60) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL7566412 | 0.78 | ACHE (0.58) | ACHEBCHE | |
| Bromide SCHEMBL29389671 | 0.78 | KDM4E (0.61) | ACHEKDM4EALDH1A1HPGDGAA | |
| Iodide SCHEMBL17187192 | 0.78 | KDM4E (0.65) | ACHEKDM4EALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3887519-B1 | METHODS OF DETERMINING PH AND CALCIUM OR CHLORIDE CONCENTRATION IN SAMPLES | UNIV CHICAGO (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12436156-B2 | Methods of determining pH and calcium or chloride concentration in samples | THE UNIVERSITY OF CHICAGO (US) | 2025-10-07 | — | — | US | disclosed |
| US-20220011325-A1 | Methods of Determining pH and Calcium or Chloride Concentration in Samples | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-01-13 | — | — | US | disclosed |
| EP-3887519-A1 | METHODS OF DETERMINING PH AND CALCIUM OR CHLORIDE CONCENTRATION IN SAMPLES | The University of Chicago (US) | 2021-10-06 | — | — | EP | disclosed |
| EP-3283236-B1 | METHOD FOR GRAFTING A COLOURED INDICATOR ONTO A SOLID SUBSTRATE AND IMPLEMENTATION KIT | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2020-09-16 | — | — | EP | disclosed |
| US-10712284-B2 | Method for grafting a coloured indicator onto a solid substrate and implementation kit | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2020-07-14 | — | — | US | disclosed |
| WO-2020117701-A1 | METHODS OF DETERMINING PH AND CALCIUM OR CHLORIDE CONCENTRATION IN SAMPLES | THE UNIVERSITY OF CHICAGO (US) | 2020-06-11 | — | — | WO | disclosed |
| US-20180120234-A1 | METHOD FOR GRAFTING A COLOURED INDICATOR ONTO A SOLID SUBSTRATE AND IMPLEMENTATION KIT | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2018-05-03 | — | — | US | disclosed |
| EP-3283236-A1 | METHOD FOR GRAFTING A COLOURED INDICATOR ONTO A SOLID SUBSTRATE AND IMPLEMENTATION KIT | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2018-02-21 | — | — | EP | disclosed |
| US-9518928-B2 | Optode for determining chemical parameters | UNIVERSITAET POTSDAM (DE) | 2016-12-13 | — | — | US | disclosed |
| WO-2016166108-A1 | METHOD FOR GRAFTING A COLOURED INDICATOR ONTO A SOLID SUBSTRATE AND IMPLEMENTATION KIT | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2016-10-20 | — | — | WO | disclosed |
| EP-2805151-B1 | OPTODE FOR DETERMINING CHEMICAL PARAMETERS | UNIVERSITÄT POTSDAM (DE) | 2016-04-06 | — | — | EP | disclosed |
| US-20150011010-A1 | OPTODE FOR DETERMINING CHEMICAL PARAMETERS | UNIVERSITAET POTSDAM (DE) | 2015-01-08 | — | — | US | disclosed |
| EP-2805151-A1 | OPTODE FOR DETERMINING CHEMICAL PARAMETERS | Universität Potsdam (DE) | 2014-11-26 | — | — | EP | disclosed |
| WO-2013107895-A1 | OPTODE FOR DETERMINING CHEMICAL PARAMETERS | UNIVERSITÄT POTSDAM (DE) | 2013-07-25 | — | — | WO | disclosed |
| US-20100035867-A1 | Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2010-02-11 | — | — | US | disclosed |
| WO-2008008704-A2 | INHIBITORS OF CYCLIC NUCLEOTIDE SYNTHESIS AND THEIR USE FOR THERAPY OF VARIOUS DISEASES | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (US) | 2008-01-17 | — | — | WO | disclosed |
| US-6063913-A | MODIFICATION OF REPEAT SEQUENCE IN EXON 6 OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE WITHOUT MODIFYING THE ENCODED AMINO ACIDS FACILITATES EXPRESSION OF PROTEIN IN BACTERIA | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 2000-05-16 | — | — | US | disclosed |
| US-5863770-A | IN VITRO PRODUCTION OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN BY EXPRESSING VARIANT GENE SEQUENCE | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1999-01-26 | — | — | US | disclosed |
| WO-1992005252-A1 | STABLE PROPAGATION OF MODIFIED FULL LENGTH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN cDNA IN HETEROLOGOUS SYSTEMS | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1992-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035867-A1 | Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases | ADCY9, ADCY3, ADCY4 | ACHE 736/4885KDM4E 3083/4885ALDH1A1 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.